This edition contains the following: New Targeted Therapy for HCC Can my patients take over-the-counter herbal and dietary supplements? NAFLD/NASH Update

This edition contains the following: TLI Welcomes Dr. Fabian Rodas Opening of Texas Liver Tumor Center (TLTC) HCC in South Texas Latinos: Is Aflatoxin Exposure Partly to Blame? A Focus on Benign

This edition contains the following: Dr. Naim Alkhouri, Joins Texas Liver Institute and UT Health Oral Nutrition Supplement for a Patient with Cirrhosis How to Make Low Sodium Diet Appealing to Patients Hepatitis

This edition contains the following: How Much Alcohol Can I Safely Drink? Does Liver Disease Hurt? Does Replacing Animal Protein With Plant Protein Help People Live Longer? Primary Biliary Cholangitis

This edition contains the following: Frequently Asked Questions on Liver Disease Managing HCV-infected Patients With Decompensated Cirrhosis Nutritional Guidelines for Fat Malabsorption in Cholestatic Liver Disease

This edition contains the following: Grazoprevir and Elbasvir Combination Therapy Portal Vein Thrombosis New Anti-Fibrotic Agent Shows Promise The NASH Pipeline 2016

This edition contains the following: Grand Opening of our Austin and McAllen Clinics Updates of Hepatitis C From EASL and Beyond Coming into the Crosshair: New Therapeutics for NASH Malnutrition

This edition contains the following: Interferon-free, All Oral DAA Regimens for Genotype 1 Ultra-short Treatments for HCV Show Promise An Update on Liver Transplantation